These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8691350

  • 1. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC, Harris AL, Gatter KC.
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL.
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 5. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
    Harpole DH, Richards WG, Herndon JE, Sugarbaker DJ.
    Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
    [Abstract] [Full Text] [Related]

  • 6. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Offersen BV, Pfeiffer P, Hamilton-Dutoit S, Overgaard J.
    Cancer; 2001 Apr 15; 91(8):1500-9. PubMed ID: 11301398
    [Abstract] [Full Text] [Related]

  • 7. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
    Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC.
    Anticancer Res; 1996 Apr 15; 16(6B):3819-25. PubMed ID: 9042264
    [Abstract] [Full Text] [Related]

  • 8. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
    Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chine S, Angeletti CA, Harris AL, Bevilacqua G.
    J Pathol; 1995 Sep 15; 177(1):57-63. PubMed ID: 7472781
    [Abstract] [Full Text] [Related]

  • 9. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.
    Br J Cancer; 2001 Sep 14; 85(6):881-90. PubMed ID: 11556841
    [Abstract] [Full Text] [Related]

  • 10. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G.
    Br J Cancer; 2000 Aug 14; 83(4):480-6. PubMed ID: 10945495
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q, Li M, Shen ZY, Xiong LW, Pan XF, Gen JF, Bao GL, Sha HF, Feng JX, Ji CY, Chen M.
    Jpn J Clin Oncol; 2010 Jul 14; 40(7):670-6. PubMed ID: 20382636
    [Abstract] [Full Text] [Related]

  • 12. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
    Angeletti CA, Lucchi M, Fontanini G, Mussi A, Chella A, Ribechini A, Vignati S, Bevilacqua G.
    Cancer; 1996 Aug 01; 78(3):409-15. PubMed ID: 8697384
    [Abstract] [Full Text] [Related]

  • 14. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.
    Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL.
    J Pathol; 1995 Nov 01; 177(3):275-83. PubMed ID: 8551390
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
    Fontanini G, De Laurentiis M, Vignati S, Chinè S, Lucchi M, Silvestri V, Mussi A, De Placido S, Tortora G, Bianco AR, Gullick W, Angeletti CA, Bevilacqua G, Ciardiello F.
    Clin Cancer Res; 1998 Jan 01; 4(1):241-9. PubMed ID: 9516978
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G, Vignati S, Boldrini L, Chinè S, Silvestri V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G.
    Clin Cancer Res; 1997 Jun 01; 3(6):861-5. PubMed ID: 9815760
    [Abstract] [Full Text] [Related]

  • 17. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
    Shimizu K, Yoshida J, Nagai K, Nishimura M, Ishii G, Morishita Y, Nishiwaki Y.
    J Thorac Cardiovasc Surg; 2005 Jul 01; 130(1):160-5. PubMed ID: 15999057
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K.
    Cancer; 2001 Mar 01; 91(5):964-71. PubMed ID: 11251948
    [Abstract] [Full Text] [Related]

  • 19. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T.
    Eur J Cardiothorac Surg; 2004 Mar 01; 25(3):443-8. PubMed ID: 15019676
    [Abstract] [Full Text] [Related]

  • 20. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E.
    J Pathol; 1999 Aug 01; 188(4):369-77. PubMed ID: 10440746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.